Insider Trading History of Mitchell Shawnte

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Mitchell Shawnte since 2018. This trader's CIK number is 1749432. At the time of last reporting, Mitchell Shawnte was the CHIEF LEGAL OFFICER of Olema Pharmaceuticals, Inc.. (stock ticker symbol OLMA). Also see all insider trading activities at Olema Pharmaceuticals, Inc..

Note that in the past Mitchell Shawnte also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Olema Pharmaceuticals, Inc. (OLMA) by Mitchell Shawnte

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2026 OLMA 0 $0 40,000 $956,900 40,000 $174,800

Yearly summary of insider trading at Aptevo Therapeutics Inc. (APVO) by Mitchell Shawnte

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 APVO 0 $0 0 $0 6,787 $0
2018 APVO 0 $0 0 $0 1,630 $0


Insider trading activities at 2 companies by Mitchell Shawnte:

1. Olema Pharmaceuticals, Inc. (OLMA)

2. Aptevo Therapeutics Inc. (APVO)

Table 1. Insider trading of Olema Pharmaceuticals, Inc. (OLMA) by Mitchell Shawnte

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2026-03-04 OLMA Option Ex 25,000 4.37 109,250
2026-03-03 OLMA Option Ex 15,000 4.37 65,550
2026-03-04 OLMA Sale 25,000 24.47 611,750
2026-03-03 OLMA Sale 15,000 23.01 345,150

Table 2. Insider trading of Aptevo Therapeutics Inc. (APVO) by Mitchell Shawnte

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-03-01 APVO Option Ex 6,787 .00 0
2018-08-09 APVO Option Ex 1,630 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mitchell Shawnte (CHIEF LEGAL OFFICER of Olema Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.